景岳 (3164)
景岳 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$45.58M, up 46.9% from a year earlier. EPS over the last four quarters totals NT$0.80.
Company profile
Data as of 2026-10-18
- Market
- TWSE-listed
- Industry
- Biotech & Medical Care
- Listed
- 2010-03-22
- Founded
- 2000-12-06
- Paid-in capital
- NT$860.10M
- Common shares issued
- 86,010,364
- Legal name
- 景岳生物科技股份有限公司
- Website
- https://www.genmont.com.tw
Monthly revenue
Data as of 2026-10-17
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$45.58M | +50.4% | +46.9% |
| 2026-08 | NT$30.30M | +10.0% | +15.5% |
Year to date: -1.5% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | 0.18 |
| 2026 Q1 | 0.05 |
| 2025 Q4 | 0.28 |
| 2025 Q3 | 0.29 |
| 2025 Q2 | -0.10 |
| 2025 Q1 | 0.19 |
| 2024 Q4 | 0.02 |
| 2024 Q3 | 0.07 |
Last four quarters: NT$0.80
Dividends
Data as of 2026-10-18
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 0.80 | 0.00 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 16,863 | 1.6% |
| 1,000–5,000 shares | 4,613 | 10.5% |
| 5,001–10,000 shares | 565 | 5.2% |
| 10,001–15,000 shares | 154 | 2.2% |
| 15,001–20,000 shares | 100 | 2.2% |
| 20,001–30,000 shares | 94 | 2.8% |
| 30,001–40,000 shares | 33 | 1.4% |
| 40,001–50,000 shares | 26 | 1.4% |
| 50,001–100,000 shares | 63 | 5.0% |
| 100,001–200,000 shares | 39 | 6.3% |
| 200,001–400,000 shares | 18 | 5.9% |
| 400,001–600,000 shares | 8 | 4.3% |
| 600,001–800,000 shares | 5 | 4.0% |
| 800,001–1,000,000 shares | 7 | 7.0% |
| 1,000,001+ shares | 15 | 40.0% |
TDCC data for 2026-10-16: 15 holders own more than 1,000 lots (40.0% of shares), and 16,863 hold less than one lot (1.6%).
Institutional net buying (last 20 trading days)
Data as of 2026-10-19
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-10-19 | -11 | 0 | 0 | -11 |
| 2026-10-16 | -1 | 0 | 0 | -1 |
| 2026-10-15 | 1 | 0 | 0 | 1 |
| 2026-10-14 | 2 | 0 | 0 | 2 |
| 2026-10-13 | 4 | 0 | 0 | 4 |
| 2026-10-12 | -2 | 0 | 2 | 0 |
| 2026-10-08 | 15 | 0 | 0 | 15 |
| 2026-10-07 | -1 | 0 | 0 | -1 |
| 2026-10-06 | 5 | 0 | 0 | 5 |
| 2026-10-05 | 4 | 0 | 0 | 4 |
| 2026-10-02 | 0 | 0 | 0 | 0 |
| 2026-10-01 | 5 | 0 | 0 | 5 |
| 2026-09-30 | 5 | 0 | 0 | 5 |
| 2026-09-29 | 31 | 0 | 0 | 31 |
| 2026-09-24 | -1 | 0 | 0 | -1 |
| 2026-09-23 | 0 | 0 | 0 | 0 |
| 2026-09-22 | 6 | 0 | 0 | 6 |
| 2026-09-21 | 7 | 0 | 1 | 8 |
| 2026-09-18 | 4 | 0 | 1 | 5 |
| 2026-09-17 | -1 | 0 | 1 | 0 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net buyers of 77 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$16.90 (2026-10-19); 52-week range NT$15.35–19.75.
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.